A drug tipped for widespread use to prevent breast cancer in post-menopausal women also accelerates loss of bone density, thus potentially boosting the risk of fractures, a study published on Tuesday said.
Related posts:
Arsenic in Organic Formula: Fake Breast Milk Still Not as Good as Real Thing
Health Highlights: April 13, 2012
Health Tip: What Constitutes 'Healthy Eating?'
'Macho' Men Do Worse in Couples When the Woman Earns More
Annual Beaches Report Finds Water Quality Lacking Along U.S. Shores
Argentine president diagnosed with thyroid cancer
Views: 0